Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence
Most patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet gui...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2019-01-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articles/stable-angina-medical-therapy-management-guidelines-critical-review-guidelines-european |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850110347627724800 |
|---|---|
| author | Talla A Rousan Udho Thadani |
| author_facet | Talla A Rousan Udho Thadani |
| author_sort | Talla A Rousan |
| collection | DOAJ |
| description | Most patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet guidelines prefer the use of beta-blockers and calcium channel blockers as a first-line treatment. The European Society of Cardiology guidelines for the management of stable coronary artery disease provide classes of recommendation with levels of evidence that are well defined. The National Institute for Health and Care Excellence (NICE) guidelines for the management of stable angina provide guidelines based on cost and effectiveness using the terms first-line and second-line therapy. Both guidelines recommend using low-dose aspirin and statins as disease-modifying agents. The aim of this article is to critically appraise the guidelines’ pharmacological recommendations for managing patients with stable angina. |
| format | Article |
| id | doaj-art-86df95ae493047dba7df85be84d05879 |
| institution | OA Journals |
| issn | 1758-3756 1758-3764 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | European Cardiology Review |
| spelling | doaj-art-86df95ae493047dba7df85be84d058792025-08-20T02:37:51ZengRadcliffe Medical MediaEuropean Cardiology Review1758-37561758-37642019-01-01141182210.15420/ecr.2018.26.1Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care ExcellenceTalla A Rousan0Udho Thadani1University of Oklahoma Health Sciences Center and Veteran Affairs Medical Center, Oklahoma City, Oklahoma, USUniversity of Oklahoma Health Sciences Center and Veteran Affairs Medical Center, Oklahoma City, Oklahoma, USMost patients with stable angina can be managed with lifestyle changes, especially smoking cessation and regular exercise, along with taking antianginal drugs. Randomised controlled trials show that antianginal drugs are equally effective and none of them reduced mortality or the risk of MI, yet guidelines prefer the use of beta-blockers and calcium channel blockers as a first-line treatment. The European Society of Cardiology guidelines for the management of stable coronary artery disease provide classes of recommendation with levels of evidence that are well defined. The National Institute for Health and Care Excellence (NICE) guidelines for the management of stable angina provide guidelines based on cost and effectiveness using the terms first-line and second-line therapy. Both guidelines recommend using low-dose aspirin and statins as disease-modifying agents. The aim of this article is to critically appraise the guidelines’ pharmacological recommendations for managing patients with stable angina.https://www.ecrjournal.com/articles/stable-angina-medical-therapy-management-guidelines-critical-review-guidelines-european |
| spellingShingle | Talla A Rousan Udho Thadani Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence European Cardiology Review |
| title | Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence |
| title_full | Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence |
| title_fullStr | Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence |
| title_full_unstemmed | Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence |
| title_short | Stable Angina Medical Therapy Management Guidelines: A Critical Review of Guidelines from the European Society of Cardiology and National Institute for Health and Care Excellence |
| title_sort | stable angina medical therapy management guidelines a critical review of guidelines from the european society of cardiology and national institute for health and care excellence |
| url | https://www.ecrjournal.com/articles/stable-angina-medical-therapy-management-guidelines-critical-review-guidelines-european |
| work_keys_str_mv | AT tallaarousan stableanginamedicaltherapymanagementguidelinesacriticalreviewofguidelinesfromtheeuropeansocietyofcardiologyandnationalinstituteforhealthandcareexcellence AT udhothadani stableanginamedicaltherapymanagementguidelinesacriticalreviewofguidelinesfromtheeuropeansocietyofcardiologyandnationalinstituteforhealthandcareexcellence |